Promises and challenges of anticancer drugs that target the epigenome.
about
Cancer heterogeneity--a multifaceted viewHistone deacetylase inhibitors with enhanced enzymatic inhibition effects and potent in vitro and in vivo antitumor activities.A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency.The future of epigenetic therapy in solid tumours--lessons from the past.Epigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals.Epigenetic therapy for solid tumors: from bench science to clinical trials.Epigenetic control and cancer: the potential of histone demethylases as therapeutic targets.Identification of new scaffolds with anti-tumor action toward human glioblastoma cells
P2860
Q26829228-B6632EE1-F63C-4658-895C-E0065B217897Q35042270-FC94BFED-1F3A-4882-9359-137C3BF8C87DQ36591414-D68E390F-74AE-4E9D-B14C-3441D3A3D3E4Q37061554-22BB2F0C-1248-4092-B639-F0ED49E131C2Q37719054-F7FFF3B8-0333-4A16-91FB-24ADAD4F8DACQ38459836-40DEDD6E-5752-4C92-B01E-1731B5787660Q42922825-7682ABA6-EC94-4EE9-BE7B-7AD150AC8505Q59080445-D9EB46D0-57B3-47FB-A899-9DF1BF09953C
P2860
Promises and challenges of anticancer drugs that target the epigenome.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Promises and challenges of anticancer drugs that target the epigenome.
@en
Promises and challenges of anticancer drugs that target the epigenome.
@nl
type
label
Promises and challenges of anticancer drugs that target the epigenome.
@en
Promises and challenges of anticancer drugs that target the epigenome.
@nl
prefLabel
Promises and challenges of anticancer drugs that target the epigenome.
@en
Promises and challenges of anticancer drugs that target the epigenome.
@nl
P2860
P356
P1433
P1476
Promises and challenges of anticancer drugs that target the epigenome.
@en
P2093
Inge Verbrugge
Michael Bots
P2860
P304
P356
10.2217/EPI.11.82
P577
2011-10-01T00:00:00Z